German pharmaceuticals and ingredients group Boehringer Ingelheim
has reported a successful first half-year, with sales in the first
six months of 2002 rising 21 per cent on the previous year to €3.7
billion and an operating income...
German pharmaceutical and ingredients group Boehringer Ingelheim,
outpacing market growth, ended 2002 with a healthy rise in profits,
the company reports this week.